Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
Clarisa M. Buckner(National Institutes of Health), Lela Kardava(National Institutes of Health), Omar El Merhebi(National Institutes of Health), Sandeep Narpala(National Institutes of Health), Leonid Serebryannyy(National Institutes of Health), Bob C. Lin(National Institutes of Health), Wei Wang(National Institutes of Health), Xiaozhen Zhang(National Institutes of Health), Felipe Lopes de Assis(National Institutes of Health), Sophie Kelly(National Institutes of Health), I‐Ting Teng(National Institutes of Health), Genevieve McCormack(National Institutes of Health), Lauren Praiss(National Institutes of Health), Catherine Seamon(National Institutes of Health Clinical Center), M. Ali Rai(National Institutes of Health), Heather Kalish(National Institutes of Health), Peter D. Kwong(National Institutes of Health), Michael A. Proschan(National Institutes of Health), Adrian B. McDermott(National Institutes of Health), Anthony S. Fauci(National Institutes of Health), Tae‐Wook Chun(National Institutes of Health), Susan Moir(National Institutes of Health)
Cited by 68Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis